Kopp Family Office’s Intersect ENT, Inc XENT Stock Holding History

Kopp Family Office’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$229K	–	13
2020 Q4	$229K	Sell	10,000 -67,630	-87%	-$1.29M	0.09%	5
2020 Q3	$1.27M	Hold	77,630	–	–	0.69%	5
2020 Q2	$1.05M	Sell	77,630 -10,000	-11%	-$116K	0.57%	5
2020 Q1	$1.04M	Buy	87,630 +12,630	+17%	+$280K	0.71%	5
2019 Q4	$1.87M	Buy	+75,000	New	+$1.52M	1.19%	4

Other funds holding XENT

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Kopp Family Office's XENT Position: Q1 2021 in Review

Kopp Family Office sold out of Intersect ENT, Inc (XENT) in Q1 2021, closing a stake of 10,000 shares — an estimated $229K sold.

Kopp Family Office first reported a position in XENT in Q4 2019 and held it in 5 quarters. The position peaked at $1.87M in Q4 2019. 108 funds tracked by Wall St. Rank hold XENT as of Q1 2021.

Kopp Family Office reported no remaining Intersect ENT, Inc position as of Q1 2021 after selling out during the quarter.
Kopp Family Office sold 10,000 Intersect ENT, Inc shares in Q1 2021, an estimated $229K.
Kopp Family Office first reported a position in Intersect ENT, Inc in Q4 2019 and held it in 5 quarters.
Kopp Family Office's Intersect ENT, Inc position peaked at $1.87M in Q4 2019.
108 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2021.

Based on Kopp Family Office's 13F filing for Q1 2021, filed 17 May 2021.